Delivery Order 36F79722D0178-19AQMM22F4148
Award Date
9/23/22
Potential Completion Date
10/6/22
Potential Value
$634K
Funding Federal Agency
Bureau of Administration
Contracting Federal Agency
Office of Acquisition Management
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This award is for a Delivery Order under Contract 36F79722D0178 for the delivery of FLUARIX and FLULAVAL influenza vaccines to the Department of State (DOS) account. The award, valued at $583,323.00, was made to Glaxosmithkline, LLC, a pharmaceutical company that provides a range of vaccines and other pharmaceutical products to U.S. government agencies. The contract is a Firm Fixed Price contract with a performance period ending on September 25, 2024. There is no set-aside designation for this...
This is a firm fixed price delivery order awarded by the Department of State's Bureau of Administration to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of FLUARIX and FLULAVAL influenza vaccines. The order, valued at $544,388.00, was issued against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The vaccines are to be delivered to a location in Sterling, Virginia. The order was awarded without any set-aside designation on July 19, 2018, with a...
The Department of State Bureau of Administration awarded a $676,710 delivery order contract to Glaxosmithkline, LLC for 2020-2021 FLUARIX and FLULAVAL QUADRIVALENT vaccines. Glaxosmithkline will deliver influenza vaccines to support the Department of State under the terms of the firm fixed price contract, which runs from July 16, 2020 through August 17, 2020. The place of performance will be Glaxosmithkline's facility in Research Triangle Park, North Carolina. No subcontractors or set aside...
This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
This federal contract award is for the delivery of the FLUARIX influenza vaccine to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The $29,385 firm fixed price contract was awarded to the prime contractor Glaxosmithkline, LLC, a foreign-owned pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The contract does not have a set-aside designation and the period of...
This federal contract award, with ID SPE2DP16D0006|0005, was issued by the Medical Supply Chain division of the Defense Logistics Agency to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The $282,870.56 firm fixed price delivery order has an ultimate completion date of November 30, 2016 and does not have a set-aside designation. Glaxosmithkline, LLC is a prime contractor that has received various federal contract and grant awards to supply...
This is a Firm Fixed Price Delivery Order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC for the FLUARIX influenza vaccine. The contract has a potential value of $165,984.00 and a completion date of October 31, 2019. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines and antiviral medications to U.S. government agencies through federal contracts. This award supports the VA's...
The U.S. government agency, the Medical Supply Chain, has awarded a $1,400.00 firm fixed price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. This contract has no set-aside designation and the performance will take place at Glaxosmithkline's facilities in Durham, North Carolina. Glaxosmithkline has also received several other federal contracts and grants to supply a range of pharmaceutical products and services, including...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC, doing business as Glaxosmithkline, a pharmaceutical company that provides vaccines and other pharmaceutical products to U.S. government agencies. The $195,624.00 delivery order is for FLUARIX R PRE-FILLED SINGLE DOSE, an influenza vaccine. The contract has a firm fixed price and no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical...
This federal contract award, SPE2DP15D0006|0008, was issued by the U.S. Defense Logistics Agency (DLA) to the prime contractor GlaxoSmithKline, LLC for the delivery of influenza virus vaccines. The $100,660.00 firm fixed price contract has a completion date of November 30, 2015 and does not have a set-aside designation. GlaxoSmithKline is a global pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contracts...